When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst sues FDA over approval of Firdapse competitor in LEMS
Catalyst Pharmaceuticals Inc.
Citing violations of its own regulations, Catalyst Pharmaceuticals (NASDAQ:CPRX) is suing the FDA over its recent approval (May 6) of Jacobus Pharmaceutical Company's Ruzurgi (amifampridine) for the treatment of children with an autoimmune disorder called Lambert-Eaton syndrome (LEMS).
More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,